We found no significant statistical difference in the PFS comparison of each sub-group with PD-L1 CPS higher than 1, 5, and 10%, PD-L1 TPS higher than 1%, and whether PD-L1 is simultaneously expressed in tumor cells and immune cells as the sub-group grouping basis (Table 3). This evidence concerns the gene CD274 and neoplasm.